Apyx Medical
APYX
56 hedge funds and large institutions have $93.1M invested in Apyx Medical in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 8 closing their positions.
138% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 8
113% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 8
90% more capital invested
Capital invested by funds: $49M → $93.1M (+$44.1M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
19% more funds holding
Funds holding: 47 → 56 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$1.66M |
| 2 |
BlackRock
New York
|
+$1.58M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$1.3M |
| 4 |
Renaissance Technologies
New York
|
+$1.2M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$981K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$1.35M |
| 2 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$659K |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$620K |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$618K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$498K |
APYX Hedge Fund Activity: Q3 2018 in Review
56 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2018, worth a combined $93.1M — up 90% from $49M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new APYX positions and 8 closed out — a net gain of 9 holders — while 19 added to existing stakes and 8 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $1.66M. The largest seller was Archon Capital Management, cutting an estimated $1.35M.
- 56 institutional investors held Apyx Medical (APYX) as of Q3 2018, up from 47 in Q2 2018.
- Funds reported $93.1M of Apyx Medical stock for Q3 2018, up 90% quarter-over-quarter.
- 17 funds opened new Apyx Medical positions in Q3 2018 and 8 closed out, a net change of +9 holders.
- The largest Apyx Medical buyer in Q3 2018 was EAM Investors, an estimated $1.66M added.
- The largest Apyx Medical seller in Q3 2018 was Archon Capital Management, an estimated $1.35M sold.
Based on aggregated 13F filings for Q3 2018.